C114H131Cl3N24O14S4 — CID 161219103
5-chloro-N-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylphenyl]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-7-amine;cyclopropanecarboxamide;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-5-yl]ethanone;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3H-pyrrolo[3,2-b]pyridin-5-yl]ethanone;4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylaniline;5,7-dichloro-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridine (PubChem CID 161219103) has the molecular formula C114H131Cl3N24O14S4 and a molecular weight of 2296.08 g/mol. Its IUPAC name is 5-chloro-N-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylphenyl]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-7-amine;cyclopropanecarboxamide;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-5-yl]ethanone;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3H-pyrrolo[3,2-b]pyridin-5-yl]ethanone;4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylaniline;5,7-dichloro-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridine.
| Compound Name | 5-chloro-N-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylphenyl]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-7-amine;cyclopropanecarboxamide;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-5-yl]ethanone;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3H-pyrrolo[3,2-b]pyridin-5-yl]ethanone;4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylaniline;5,7-dichloro-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridine |
|---|---|
| PubChem CID | 161219103 |
| Molecular Formula | C114H131Cl3N24O14S4 |
| Molecular Weight | 2296.08 g/mol |
| Exact Mass | 2292.82 |
| IUPAC Name | 5-chloro-N-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylphenyl]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-7-amine;cyclopropanecarboxamide;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridin-5-yl]ethanone;1-cyclopropyl-2-[7-[4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylanilino]-2-methyl-3H-pyrrolo[3,2-b]pyridin-5-yl]ethanone;4-(1-cyclopropyl-5-methylpyrazol-4-yl)-2-methylsulfonylaniline;5,7-dichloro-2-methyl-3-(oxan-2-yl)imidazo[4,5-b]pyridine |
| SMILES | CC1=Nc2c(Nc3ccc(-c4cnn(C5CC5)c4C)cc3S(C)(=O)=O)cc(CC(=O)C3CC3)nc2C1.Cc1c(-c2ccc(N)c(S(C)(=O)=O)c2)cnn1C1CC1.Cc1c(-c2ccc(Nc3cc(CC(=O)C4CC4)nc4c3nc(C)n4C3CCCCO3)c(S(C)(=O)=O)c2)cnn1C1CC1.Cc1c(-c2ccc(Nc3cc(Cl)nc4c3nc(C)n4C3CCCCO3)c(S(C)(=O)=O)c2)cnn1C1CC1.Cc1nc2c(Cl)cc(Cl)nc2n1C1CCCCO1.NC(=O)C1CC1 |
| InChI | InChI=1S/C31H36N6O4S.C27H29N5O3S.C26H29ClN6O3S.C14H17N3O2S.C12H13Cl2N3O.C4H7NO/c1-18-24(17-32-37(18)23-10-11-23)21-9-12-25(28(14-21)42(3,39)40)35-26-15-22(16-27(38)20-7-8-20)34-31-30(26)33-19(2)36(31)29-6-4-5-13-41-29;1-15-10-23-27(29-15)24(12-19(30-23)13-25(33)17-4-5-17)31-22-9-6-18(11-26(22)36(3,34)35)21-14-28-32(16(21)2)20-7-8-20;1-15-19(14-28-33(15)18-8-9-18)17-7-10-20(22(12-17)37(3,34)35)30-21-13-23(27)31-26-25(21)29-16(2)32(26)24-6-4-5-11-36-24;1-9-12(8-16-17(9)11-4-5-11)10-3-6-13(15)14(7-10)20(2,18)19;1-7-15-11-8(13)6-9(14)16-12(11)17(7)10-4-2-3-5-18-10;5-4(6)3-1-2-3/h9,12,14-15,17,20,23,29H,4-8,10-11,13,16H2,1-3H3,(H,34,35);6,9,11-12,14,17,20H,4-5,7-8,10,13H2,1-3H3,(H,30,31);7,10,12-14,18,24H,4-6,8-9,11H2,1-3H3,(H,30,31);3,6-8,11H,4-5,15H2,1-2H3;6,10H,2-5H2,1H3;3H,1-2H2,(H2,5,6) |
| InChIKey | UXGMVJOMXINHIV-UHFFFAOYSA-N |
| XLogP | 22.07 |
| TPSA | 492.25 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 159 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2296.08 |
| LogP ≤ 5 | 22.07 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 37 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|